Mechanism for miR-21-modulated radioresistance

miR-21 调节的放射抗性机制

基本信息

  • 批准号:
    8976599
  • 负责人:
  • 金额:
    $ 20.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-12-01 至 2017-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Radiotherapy is a common cancer therapeutic approach but radioresistance in tumors frequently prevents successful cancer control; therefore, overcoming radioresistance is essential for improving radiotherapy. MicroRNA-21 (miR-21) is an onco-miR that over- expresses in almost all types of human tumors. We and others have demonstrated that over- expression of miR-21 could result in tumorigenesis. Currently, there are only a few reports showed that miR-21 contributes to radioresistance of tumor cells, and the mechanism remains unclear. Recently, by using our miR-21 knock-in or miR-21 knockout mouse models, the embryo fibroblast cells derived from the mouse strains and knocking down miR-21 in several human tumor cell lines, we found that miR-21 plays an important role in radioresistance that is involved in promoting DNA double strand break (DSB) repair. Based on our previous publications and preliminary data, we will test the hypothesis that miR-21-mediated radioresistance occurs through its targets to promote DNA DSB repair. Since IR-induced cell killing occurs mainly by generating DSBs, and non-homologous end joining (NHEJ) and homologous recombination repair (HRR) are the two major pathways in mammalian cells to repair DNA DSB, it is important to elucidate if miR-21-mediated radioresistance occurs through stimulating NHEJ, HRR or both. It is also important to elucidate how miR-21 affects the DNA repair pathway(s) via its targets including Pten and Cdc25A (known targets of miR-21), as well as GSK3b (a novel target of miR- 21 identified by our group). For this purpose, two aims are designed: 1) Determine if miR-21- mediated radioresistance occurs through stimulating NHEJ, HRR or both. 2) Determine how miR-21 mediates radioresistance through its targets. Since miR-21 over-expressed in almost all types of human tumors, the results from this proposal are expected to not only enhance our knowledge of tumor cell radioresistance, but also provide novel targets and pathways for improving tumor radiotherapy.
描述(由申请人提供):放射治疗是一种常见的癌症治疗方法,但肿瘤的放射耐药性经常阻碍成功的癌症控制;因此,克服放射耐药是改善放射治疗的关键。MicroRNA-21 (miR-21)是一种在几乎所有类型的人类肿瘤中过表达的onco-miR。我们和其他人已经证明过表达miR-21可能导致肿瘤发生。目前仅有少数报道显示miR-21参与肿瘤细胞的放射耐药,其机制尚不清楚。最近,通过我们的miR-21敲入或miR-21敲除小鼠模型,来自小鼠品系的胚胎成纤维细胞和敲除几种人类肿瘤细胞系中的miR-21,我们发现miR-21在辐射抗性中起重要作用,参与促进DNA双链断裂(DSB)修复。基于我们之前的出版物和初步数据,我们将验证mir -21介导的辐射耐药是通过其靶点促进DNA DSB修复而发生的。由于ir诱导的细胞杀伤主要通过产生DSB发生,而非同源末端连接(non-homologous end joining, NHEJ)和同源重组修复(homologous recombination repair, HRR)是哺乳动物细胞修复DNA DSB的两种主要途径,因此阐明mir -21介导的辐射耐药是通过刺激NHEJ、HRR还是两者同时发生是很重要的。阐明miR-21如何通过其靶点包括Pten和Cdc25A (miR-21的已知靶点)以及GSK3b(我们小组发现的miR-21的新靶点)影响DNA修复途径也很重要。为此,设计了两个目标:1)确定miR-21介导的辐射耐药是否通过刺激NHEJ、HRR或两者同时发生。2)确定miR-21如何通过其靶标介导辐射抗性。由于miR-21在几乎所有类型的人类肿瘤中都过表达,因此本研究的结果不仅可以增强我们对肿瘤细胞放射抵抗的认识,还可以为改善肿瘤放疗提供新的靶点和途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YA WANG其他文献

YA WANG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YA WANG', 18)}}的其他基金

miR-21 signaling in tumor response to radiation treatment
miR-21信号传导在肿瘤对放射治疗的反应中
  • 批准号:
    8693551
  • 财政年份:
    2014
  • 资助金额:
    $ 20.36万
  • 项目类别:
miR-21 signaling in tumor response to radiation treatment
miR-21信号传导在肿瘤对放射治疗的反应中
  • 批准号:
    9247145
  • 财政年份:
    2014
  • 资助金额:
    $ 20.36万
  • 项目类别:
A new role of MEPE/OF45 as a co-factor of CHK1 for DNA damage response
MEPE/OF45 作为 CHK1 辅助因子在 DNA 损伤反应中的新作用
  • 批准号:
    7917069
  • 财政年份:
    2009
  • 资助金额:
    $ 20.36万
  • 项目类别:
A new role of MEPE/OF45 as a co-factor of CHK1 for DNA damage response
MEPE/OF45 作为 CHK1 辅助因子在 DNA 损伤反应中的新作用
  • 批准号:
    7678912
  • 财政年份:
    2007
  • 资助金额:
    $ 20.36万
  • 项目类别:
A new role of MEPE/OF45 as a co-factor of CHK1 for DNA damage response
MEPE/OF45 作为 CHK1 辅助因子在 DNA 损伤反应中的新作用
  • 批准号:
    7373813
  • 财政年份:
    2007
  • 资助金额:
    $ 20.36万
  • 项目类别:
A new role of MEPE/OF45 as a co-factor of CHK1 for DNA damage response
MEPE/OF45 作为 CHK1 辅助因子在 DNA 损伤反应中的新作用
  • 批准号:
    7498484
  • 财政年份:
    2007
  • 资助金额:
    $ 20.36万
  • 项目类别:
A new role of MEPE/OF45 as a co-factor of CHK1 for DNA damage response
MEPE/OF45 作为 CHK1 辅助因子在 DNA 损伤反应中的新作用
  • 批准号:
    7907522
  • 财政年份:
    2007
  • 资助金额:
    $ 20.36万
  • 项目类别:
REGULATION OF DNA IN CAMPTOTHECIN TREATED CELLS
喜树碱处理细胞中 DNA 的调节
  • 批准号:
    6475938
  • 财政年份:
    1997
  • 资助金额:
    $ 20.36万
  • 项目类别:
REGULATION OF DNA IN CAMPTOTHECIN TREATED CELLS
喜树碱处理细胞中 DNA 的调节
  • 批准号:
    2837768
  • 财政年份:
    1997
  • 资助金额:
    $ 20.36万
  • 项目类别:
REGULATION OF DNA IN CAMPTOTHECIN TREATED CELLS
喜树碱处理细胞中 DNA 的调节
  • 批准号:
    6124432
  • 财政年份:
    1997
  • 资助金额:
    $ 20.36万
  • 项目类别:

相似海外基金

Life outside institutions: histories of mental health aftercare 1900 - 1960
机构外的生活:1900 - 1960 年心理健康善后护理的历史
  • 批准号:
    DP240100640
  • 财政年份:
    2024
  • 资助金额:
    $ 20.36万
  • 项目类别:
    Discovery Projects
Development of a program to promote psychological independence support in the aftercare of children's homes
制定一项计划,促进儿童之家善后护理中的心理独立支持
  • 批准号:
    23K01889
  • 财政年份:
    2023
  • 资助金额:
    $ 20.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Integrating Smoking Cessation in Tattoo Aftercare
将戒烟融入纹身后护理中
  • 批准号:
    10452217
  • 财政年份:
    2022
  • 资助金额:
    $ 20.36万
  • 项目类别:
Integrating Smoking Cessation in Tattoo Aftercare
将戒烟融入纹身后护理中
  • 批准号:
    10670838
  • 财政年份:
    2022
  • 资助金额:
    $ 20.36万
  • 项目类别:
Aftercare for young people: A sociological study of resource opportunities
年轻人的善后护理:资源机会的社会学研究
  • 批准号:
    DP200100492
  • 财政年份:
    2020
  • 资助金额:
    $ 20.36万
  • 项目类别:
    Discovery Projects
Creating a National Aftercare Strategy for Survivors of Pediatric Cancer
为小儿癌症幸存者制定国家善后护理策略
  • 批准号:
    407264
  • 财政年份:
    2019
  • 资助金额:
    $ 20.36万
  • 项目类别:
    Operating Grants
Aftercare of green infrastructure: creating algorithm for resolving human-bird conflicts
绿色基础设施的善后工作:创建解决人鸟冲突的算法
  • 批准号:
    18K18240
  • 财政年份:
    2018
  • 资助金额:
    $ 20.36万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of an aftercare model for children who have experienced invasive procedures
为经历过侵入性手术的儿童开发善后护理模型
  • 批准号:
    17K12379
  • 财政年份:
    2017
  • 资助金额:
    $ 20.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a Comprehensive Aftercare Program for children's self-reliance support facility
为儿童自力更生支持设施制定综合善后护理计划
  • 批准号:
    17K13937
  • 财政年份:
    2017
  • 资助金额:
    $ 20.36万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Project#2 Extending Treatment Effects Through an Adaptive Aftercare Intervention
项目
  • 批准号:
    8742767
  • 财政年份:
    2014
  • 资助金额:
    $ 20.36万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了